Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease - PubMed (original) (raw)
Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease
William S Mow et al. Gastroenterology. 2004 Feb.
Abstract
Background & aims: Crohn's disease patients can be characterized by antibody responses against Crohn's disease-related bacterial sequence, Escherichia coli outer membrane porin C, Saccharomyces cerevisiae (oligomannan), and neutrophil nuclear antigens. Our aim was to determine whether expression of antibodies against Crohn's disease-related bacterial sequence and Escherichia coli outer membrane porin C is associated with distinct phenotypic manifestations.
Methods: Sera from 303 patients were tested for antibodies to the Crohn's disease-related bacterial sequence (I2), anti-Escherichia coli outer membrane porin C, anti-Saccharomyces cerevisiae, and perinuclear antineutrophil cytoplasmic antibodies and for 3 Crohn's disease-associated variants of the NOD2 gene (R702W, G908R, and 1007fs) and compared with clinical data.
Results: Patients expressing I2 were more likely to have fibrostenosing Crohn's disease (64.4% vs. 40.7%; P < 0.001) and to require small bowel surgery (62.2% vs. 37.4%; P < 0.001). Patients with anti-Escherichia coli outer membrane porin C were more likely to have internal perforating disease (50.0% vs. 30.7%; P = 0.001) and to require small bowel surgery (61.4% vs. 44.2%; P = 0.003). Anti-Crohn's disease-related bacterial sequence was independently associated with fibrostenosis (P = 0.027) and small bowel surgery (P = 0.01), whereas anti-Escherichia coli outer membrane porin C was independently associated with internal perforations (P < 0.006). Patients positive for I2, anti-Escherichia coli outer membrane porin C, and anti-Saccharomyces cerevisiae were the most likely to have undergone small bowel surgery (72.0%; odds ratio, 8.6; P < 0.001) compared with patients without reactivity (23.0%). When the presence and magnitude of antibody responses were considered, 90% of patients with small bowel disease who required surgery had high levels of I2, Escherichia coli outer membrane porin C, and oligomannan antibodies, compared with only 18.2% with low-titer responses (P < 0.001).
Conclusions: I2 and anti-Escherichia coli outer membrane porin C are associated with Crohn's disease phenotypes, and patients with the highest level of serum reactivity toward an increasing number of microbiota have the greatest frequency of strictures, internal perforations, and small bowel surgery.
Comment in
- Antibody responses in Crohn's disease.
Vermeire S, Rutgeerts P. Vermeire S, et al. Gastroenterology. 2004 Feb;126(2):601-4. doi: 10.1053/j.gastro.2003.12.020. Gastroenterology. 2004. PMID: 14762797 Review. No abstract available.
Similar articles
- Anti-flagellin (CBir1) phenotypic and genetic Crohn's disease associations.
Papadakis KA, Yang H, Ippoliti A, Mei L, Elson CO, Hershberg RM, Vasiliauskas EA, Fleshner PR, Abreu MT, Taylor K, Landers CJ, Rotter JI, Targan SR. Papadakis KA, et al. Inflamm Bowel Dis. 2007 May;13(5):524-30. doi: 10.1002/ibd.20106. Inflamm Bowel Dis. 2007. PMID: 17260364 - Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens.
Landers CJ, Cohavy O, Misra R, Yang H, Lin YC, Braun J, Targan SR. Landers CJ, et al. Gastroenterology. 2002 Sep;123(3):689-99. doi: 10.1053/gast.2002.35379. Gastroenterology. 2002. PMID: 12198693 - Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype.
Arnott ID, Landers CJ, Nimmo EJ, Drummond HE, Smith BK, Targan SR, Satsangi J. Arnott ID, et al. Am J Gastroenterol. 2004 Dec;99(12):2376-84. doi: 10.1111/j.1572-0241.2004.40417.x. Am J Gastroenterol. 2004. PMID: 15571586 - [Relevance of serologic studies in inflammatory bowel diseases].
Papp M, Altorjay I, Lakatos PL. Papp M, et al. Orv Hetil. 2007 May 13;148(19):887-96. doi: 10.1556/OH.2007.28064. Orv Hetil. 2007. PMID: 17478404 Review. Hungarian. - Serologic markers in inflammatory bowel disease: state of the art.
Sandborn WJ. Sandborn WJ. Rev Gastroenterol Disord. 2004 Fall;4(4):167-74. Rev Gastroenterol Disord. 2004. PMID: 15580151 Review.
Cited by
- Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn's disease, and ulcerative colitis patients.
Plevy S, Silverberg MS, Lockton S, Stockfisch T, Croner L, Stachelski J, Brown M, Triggs C, Chuang E, Princen F, Singh S. Plevy S, et al. Inflamm Bowel Dis. 2013 May;19(6):1139-48. doi: 10.1097/MIB.0b013e318280b19e. Inflamm Bowel Dis. 2013. PMID: 23518807 Free PMC article. - Increased epithelial gaps in the small intestine are predictive of hospitalization and surgery in patients with inflammatory bowel disease.
Turcotte JF, Wong K, Mah SJ, Dieleman LA, Kao D, Kroeker K, Claggett B, Saltzman JR, Wine E, Fedorak RN, Liu JJ. Turcotte JF, et al. Clin Transl Gastroenterol. 2012 Jul 26;3(7):e19. doi: 10.1038/ctg.2012.13. Clin Transl Gastroenterol. 2012. PMID: 23238291 Free PMC article. - Moderate exercise training attenuates the severity of experimental rodent colitis: the importance of crosstalk between adipose tissue and skeletal muscles.
Bilski J, Mazur-Bialy AI, Brzozowski B, Magierowski M, Jasnos K, Krzysiek-Maczka G, Urbanczyk K, Ptak-Belowska A, Zwolinska-Wcislo M, Mach T, Brzozowski T. Bilski J, et al. Mediators Inflamm. 2015;2015:605071. doi: 10.1155/2015/605071. Epub 2015 Jan 5. Mediators Inflamm. 2015. PMID: 25684862 Free PMC article. - Management of active Crohn disease.
Cheifetz AS. Cheifetz AS. JAMA. 2013 May 22;309(20):2150-8. doi: 10.1001/jama.2013.4466. JAMA. 2013. PMID: 23695484 Free PMC article. Review. - Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease.
Henckaerts L, Pierik M, Joossens M, Ferrante M, Rutgeerts P, Vermeire S. Henckaerts L, et al. Gut. 2007 Nov;56(11):1536-42. doi: 10.1136/gut.2007.125468. Epub 2007 Jun 26. Gut. 2007. PMID: 17595233 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical